Solid Biosciences, Inc. (SLDB)
9.93
-0.32
(-3.12%)
USD |
NASDAQ |
Sep 08, 16:00
9.80
-0.13
(-1.31%)
After-Hours: 07:04
Solid Biosciences Market Cap : 1.044B for Sept. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 1.044B |
| September 04, 2026 | 1.078B |
| September 03, 2026 | 1.095B |
| September 02, 2026 | 1.081B |
| September 01, 2026 | 1.039B |
| August 31, 2026 | 1.007B |
| August 28, 2026 | 1.027B |
| August 27, 2026 | 1.065B |
| August 26, 2026 | 1.022B |
| August 25, 2026 | 1.040B |
| August 24, 2026 | 962.95M |
| August 21, 2026 | 977.67M |
| August 20, 2026 | 956.64M |
| August 19, 2026 | 1.024B |
| August 18, 2026 | 954.54M |
| August 17, 2026 | 956.64M |
| August 14, 2026 | 967.15M |
| August 13, 2026 | 954.54M |
| August 12, 2026 | 952.96M |
| August 11, 2026 | 930.36M |
| August 10, 2026 | 899.87M |
| August 07, 2026 | 882.00M |
| August 06, 2026 | 915.64M |
| August 05, 2026 | 917.74M |
| August 04, 2026 | 906.18M |
| Date | Value |
|---|---|
| August 03, 2026 | 789.13M |
| July 31, 2026 | 793.06M |
| July 30, 2026 | 835.37M |
| July 29, 2026 | 791.09M |
| July 28, 2026 | 784.21M |
| July 27, 2026 | 776.33M |
| July 24, 2026 | 770.43M |
| July 23, 2026 | 785.19M |
| July 22, 2026 | 797.00M |
| July 21, 2026 | 832.42M |
| July 20, 2026 | 831.44M |
| July 17, 2026 | 858.00M |
| July 16, 2026 | 890.47M |
| July 15, 2026 | 946.56M |
| July 14, 2026 | 947.54M |
| July 13, 2026 | 956.40M |
| July 10, 2026 | 1.025B |
| July 09, 2026 | 1.096B |
| July 08, 2026 | 1.082B |
| July 07, 2026 | 1.097B |
| July 06, 2026 | 1.089B |
| July 02, 2026 | 1.067B |
| July 01, 2026 | 1.004B |
| June 30, 2026 | 982.96M |
| June 29, 2026 | 931.80M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 316.63M |
| Amgen, Inc. | 212.55B |
| Anika Therapeutics, Inc. | 281.58M |
| BioCryst Pharmaceuticals, Inc. | 2.314B |
| Imunon, Inc. | 7.185M |
Market Cap Related Metrics
| Price to Book Value | 2.791 |
| Price | 9.93 |
| Earnings Yield | -19.22% |